UBS analyst Brian Meredith lowered the firm’s price target on Arch Capital (ACGL) to $124 from $127 and keeps a Buy rating on the shares. UBS likes the defensive nature of P&C insurance heading into 1Q25 results, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACGL:
- Arch Capital price target lowered to $104 from $113 at Keefe Bruyette
- Arch Capital price target raised to $107 from $106 at JPMorgan
- Positive Outlook for Arch Capital Group Driven by Strong Reserve Management and Strategic Risk Practices
- Arch Capital price target lowered to $113 from $120 at Keefe Bruyette
- Arch Capital price target lowered to $110 from $125 at RBC Capital